L S Shimanovskaia

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
During 73 single contrast investigations with 76% triobrast, 76% verographin, 76% urographin, urotrast and omnipaque-300, 65% of patients had clinical adverse reactions which were mainly mild. In 79% of cases, the syndrome of side effects consisted of one clinical manifestation. The occurrence of clinical adverse reactions caused by diatrizoate derivatives(More)
  • 1